Detalles de la búsqueda
1.
Molecular determinants of clinical outcomes of pembrolizumab in recurrent ovarian cancer: Exploratory analysis of KEYNOTE-100.
Gynecol Oncol
; 178: 119-129, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37862791
2.
Blood tumor mutational burden and response to pembrolizumab plus chemotherapy in non-small cell lung cancer: KEYNOTE-782.
Lung Cancer
; 190: 107506, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38422883
3.
Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC.
JTO Clin Res Rep
; 4(1): 100431, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36793385
4.
Association between gene expression signatures and clinical outcomes of pembrolizumab versus paclitaxel in advanced gastric cancer: exploratory analysis from the randomized, controlled, phase III KEYNOTE-061 trial.
J Immunother Cancer
; 11(6)2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37399357
5.
Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results.
Nat Med
; 29(7): 1718-1727, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37429923
6.
Transcriptomic Determinants of Response to Pembrolizumab Monotherapy across Solid Tumor Types.
Clin Cancer Res
; 28(8): 1680-1689, 2022 04 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34965943
7.
Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study.
Clin Cancer Res
; 28(16): 3489-3498, 2022 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35657979
8.
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
JCO Precis Oncol
; 6: e2100372, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35952319
9.
Five Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death-Ligand 1-Positive Advanced NSCLC.
J Thorac Oncol
; 16(10): 1718-1732, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34048946
10.
Pharmacogenetic Analysis of OATP1B1, UGT1A1, and BCRP Variants in Relation to the Pharmacokinetics of Letermovir in Previously Conducted Clinical Studies.
J Clin Pharmacol
; 59(9): 1236-1243, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31022310
11.
National disparities in treatment package time for resected locally advanced head and neck cancer and impact on overall survival.
Head Neck
; 40(6): 1147-1155, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29394465
12.
Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis.
J Acquir Immune Defic Syndr
; 79(4): 421-429, 2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30211722
13.
Genetic sharing and heritability of paediatric age of onset autoimmune diseases.
Nat Commun
; 6: 8442, 2015 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26450413
14.
Restraint of the G2/M transition by the SR/RRM family mRNA shuttling binding protein SNXAHRB1 in Aspergillus nidulans.
Genetics
; 198(2): 617-33, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25104516
Resultados
1 -
14
de 14
1
Próxima >
>>